Hyrimoz 40 mg Pre-Filled Syringe: SmPC Summary
Quick summary Hyrimoz 40 mg solution for injection in a pre-filled syringe is a biosimilar medicine used for inflammatory autoimmune conditions. This page summarises the product characteristics in plain English for pharmacists and other...
This content is for educational purposes only and does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.
Quick summary
Hyrimoz 40 mg solution for injection in a pre-filled syringe is a biosimilar medicine used for inflammatory autoimmune conditions. This page summarises the product characteristics in plain English for pharmacists and other healthcare readers.
Medical disclaimer: This article is for general information only and does not replace the official SmPC, patient leaflet, or advice from a qualified healthcare professional. Always verify product details, indications, and administration instructions from the current official documents.
What Hyrimoz 40 mg is
Hyrimoz is a biosimilar medicine used in the treatment of several autoimmune and chronic inflammatory conditions. It is a tumour necrosis factor alpha (TNF-α) inhibitor, which means it works by blocking a substance involved in inflammation.
This article focuses on the 40 mg solution for injection in a pre-filled syringe and provides a practical summary of the product characteristics.
How Hyrimoz works
Hyrimoz binds to TNF-α and neutralises its activity. By reducing TNF-α activity, it helps lower inflammation associated with autoimmune disease.
As a biosimilar, Hyrimoz is designed to be highly similar to its reference biologic product. Healthcare professionals should always refer to the official product information for the exact approved use and administration details.
Approved uses mentioned in the source content
The source content identifies Hyrimoz as being used for moderate to severe rheumatoid arthritis and other autoimmune conditions. These include:
- Psoriatic arthritis
- Crohn’s disease
- Ulcerative colitis
- Ankylosing spondylitis
Because indications can vary by product presentation and market, readers should confirm the exact licensed indications in the current SmPC.
Administration overview
The source content describes Hyrimoz as a pre-filled syringe formulation. Proper administration technique is important, and patients should receive training from a healthcare professional before self-injection.
General points mentioned in the source include:
- Allow the syringe to reach room temperature before use, if instructed in the leaflet.
- Choose an appropriate injection site.
- Rotate injection sites to help reduce local irritation.
- Dispose of used syringes in a suitable sharps container.
Do not rely on this summary alone for injection instructions. Always follow the official leaflet and local clinical guidance.
Injection sites mentioned in the source
- Thigh
- Abdomen, avoiding the navel area
- Outer upper arm
Injection should be avoided in skin that is bruised, scarred, or infected.
Common side effects mentioned in the source
The source content lists the following as common side effects:
- Injection site reactions such as redness, swelling, or pain
- Headache
- Nausea
- Fatigue
Side effects can vary between patients. Any suspected adverse reaction should be assessed using the official product information and local reporting procedures.
Hyrimoz and Humira
The source content states that Hyrimoz is a biosimilar to Humira. Both are TNF-α inhibitors and are used in inflammatory conditions.
For pharmacists and prescribers, the key practical point is that biosimilar use should always be guided by the approved product information, local policy, and the patient’s clinical context.
Practical points for pharmacists
| Topic | What to verify |
|---|---|
| Presentation | Confirm the exact strength and device type: 40 mg pre-filled syringe, low concentration. |
| Indication | Check the current SmPC for the approved condition and age group. |
| Administration | Follow the official leaflet for preparation, injection technique, and disposal. |
| Safety | Review the leaflet for warnings, interactions, and adverse reaction reporting. |
Frequently asked questions
▸ What is Hyrimoz 40 mg used for?
The source content describes Hyrimoz 40 mg as being used for moderate to severe rheumatoid arthritis and other autoimmune inflammatory conditions. Always confirm the exact licensed indication in the current SmPC.
▸ Is Hyrimoz a biosimilar?
Yes. The source content identifies Hyrimoz as a biosimilar medicine and a TNF-α inhibitor.
▸ What side effects are mentioned in the source?
The source content mentions injection site reactions, headache, nausea, and fatigue.
▸ Where can Hyrimoz be injected?
The source content lists the thigh, abdomen away from the navel, and outer upper arm as injection sites.
▸ How does Hyrimoz compare with Humira?
The source content says Hyrimoz is a biosimilar to Humira and shares a similar TNF-α inhibiting mechanism. Product selection should follow the approved information and local clinical guidance.
▸ What should be checked before use?
Readers should verify the current SmPC, patient leaflet, storage instructions, injection technique, and any local pharmacy or prescribing requirements.
Safety reminder: Before administration or counselling, always check the current official SmPC and patient leaflet. If a patient has questions about side effects, injection technique, or suitability, refer them to the prescribing clinician or pharmacist.
Medical disclaimer
This content is for educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis or treatment. Always ask a doctor, pharmacist or qualified healthcare professional before starting, stopping or changing any medicine.
Sources and verification
The following sources or official references are listed to support verification of the medicine information discussed in this article.
Medicine information can change and may vary depending on country, product formulation, patient history and professional guidance. Always check official medicine information and ask a healthcare professional for personal medical questions.